New drug NB02 tested for tough lymphoma cases
Disease control
Recruiting now
This early-phase trial tests a new drug called NB02 (posseltinib) in about 9 adults with certain types of Non-Hodgkin lymphoma (follicular, mantle cell, or marginal zone) that have returned or not responded to at least two prior treatments. The main goals are to find a safe dose …
Phase: PHASE1 • Sponsor: NOBO Medicine • Aim: Disease control
Last updated May 17, 2026 08:04 UTC